Pancreatic Cancer Research

ResearcherThe University of MelbourneActive in the last 2 years

Prasad D. Cooray

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-7230-2374; OpenAlex author ID A5011918904. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Progress and challenges in expanding access to clinical trials in pancreatic cancer. Co-author DOI 10.1038/s43856-026-01869-z↗
  2. A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma. Last author DOI 10.1186/s12885-026-16113-z↗
  3. Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and … Last author DOI 10.1007/s12029-025-01237-5↗
  4. Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population. Co-author DOI 10.1111/ajco.13807↗
  5. Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia. Co-author DOI 10.1111/imj.15094↗
  6. Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer. Co-author DOI 10.1093/annonc/mdz200↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sue S. Thang · 2 shared papers, 2026 · strength 0.64
  2. Ashleigh R. Poh · 2 shared papers, 2026 · strength 0.64
  3. Vijayaragavan Muralidharan · 2 shared papers, 2025–2026 · strength 0.58
  4. Adrian M. Fox · 2 shared papers, 2023–2026 · strength 0.41
  5. Andrew J. Metz · 1 shared paper, 2026 · strength 0.36
  6. Peter Gibbs · 3 shared papers, 2019–2023 · strength 0.35
  7. Belinda Lee · 3 shared papers, 2019–2023 · strength 0.35
  8. Kevin Zhao · 1 shared paper, 2025 · strength 0.30
  9. Benjamin N. J. Thomson · 2 shared papers, 2019–2023 · strength 0.20
  10. Adnan M. Nagrial · 2 shared papers, 2019–2023 · strength 0.20
  11. Matthew Burge · 2 shared papers, 2019–2023 · strength 0.20
  12. Niall Christopher Tebbutt · 2 shared papers, 2019–2023 · strength 0.20
  13. Marion Harris · 2 shared papers, 2019–2023 · strength 0.20
  14. Mehrdad Nikfarjam · 2 shared papers, 2019–2023 · strength 0.20
  15. Amy L. Body · 1 shared paper, 2022 · strength 0.15
  16. Margaret Lee · 1 shared paper, 2022 · strength 0.15
  17. Imogen Walpole · 1 shared paper, 2023 · strength 0.14
  18. Bert Vogelstein · 1 shared paper, 2019 · strength 0.07
  19. Nickolas Papadopoulos · 1 shared paper, 2019 · strength 0.07
  20. David Goldstein · 1 shared paper, 2019 · strength 0.07
  21. Ben J. Lawrence · 1 shared paper, 2019 · strength 0.07
  22. Andrew Mark Haydon · 1 shared paper, 2019 · strength 0.07
  23. Kenneth W. Kinzler · 1 shared paper, 2019 · strength 0.07
  24. Christopher Lee Wolfgang · 1 shared paper, 2019 · strength 0.07
  25. David Wai-Meng Tai · 1 shared paper, 2019 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.